ProCE Banner Activity

Expert Insights on Optimal Current Management of Patients With Cholangiocarcinoma

Podcast Episodes
In an engaging discussion, Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP, share how they currently treat patients with cholangiocarcinoma, including initial diagnosis, biomarker testing to guide treatment, adverse event management, and patient counseling.

Released: March 21, 2022

Expiration: March 20, 2023

No longer available for credit.

Share

Faculty

Christine Chio

Christine Chio, PharmD, BCOP

Clinical Ambulatory GI Oncology Pharmacist
Department of Pharmacy
Massachusetts General Hospital
Boston, Massachusetts

Lipika Goyal

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Caroline Kuhlman

Caroline Kuhlman, NP

Nurse Practitioner
GI Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Incyte Corporation

Faculty Disclosure

Primary Author

Christine Chio, PharmD, BCOP

Clinical Ambulatory GI Oncology Pharmacist
Department of Pharmacy
Massachusetts General Hospital
Boston, Massachusetts

Christine Chio, PharmD, BCOP, has no relevant conflicts of interest to disclose.

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Lipika Goyal, MD, has received funds for research paid to her institution from Adaptimmune, Bayer, Bristol Meyers Squibb, Eisai, Genentech, Merck, Incyte, Leap Therapeutics, Lilly, Loxo Oncology, Macrogenics, Novartis, NuCana, QED, Relay Therapeutics, Servier, and Taiho; consultant/advisory fees from Alentis, Black Diamond, Genentech, Exelixis, H3 Biomedicine, Incyte, QED, Servier, Sirtex, and Taiho; and funds as a part of the Data Safety Monitoring Committee for AstraZeneca.

Caroline Kuhlman, NP

Nurse Practitioner
GI Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Caroline Kuhlman, NP has no relevant conflicts of interest to disclose.